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The aim of the current study was
•To develop and characterize a co-encapsulated nanoparticle system consisting of quercetin and β-
carotene using biodegradable polymers, PLA and PLGA
•To investigate the antioxidant activity of quercetin and β-carotene when incorporated in a single- and
co-encapsulated nanoparticle system.
Sample Polymer Used Mean Size (nm) Mean zeta potential
Blank PLGA 50:50 284 ± 14 -0.8
Blank PLGA 75:25 244 ± 12 -30.6
Blank PLA 267 ± 13 -24.0
Single encapsulated β-Carotene PLA 268 ± 13 -15.4
Single encapsulated β-Carotene PLGA 50:50 229 ± 11 -10.2
Single encapsulated β-Carotene PLGA 75:25 252 ± 13 -9.2
Single encapsulated Quercetin PLA 263 ± 13 -26.6
Single encapsulated Quercetin PLGA 50:50 281 ± 14 -22.2
Single encapsulated Quercetin PLGA 75:25 264 ± 13 -7.7
Co-encapsulated β-carotene and Quercetin PLGA 50:50 277 ± 14 -15.1
Co-encapsulated β-carotene and Quercetin PLGA 75:25 282 ± 14 -41.6
Co-encapsulated β-carotene and Quercetin PLA 270 ± 12 -35.4
Loading efficiency (%)
Sample Polymer β-carotene Quercetin
Single encapsulated β-carotene PLGA 50:50 1.75 ± 0.09 -
Single encapsulated β-carotene PLGA 75:25 0.86  ± 0.04 -
Single encapsulated β-carotene PLA 0.34 ± 0.02 -
Single encapsulated Quercetin PLGA 50:50 - 11.62 ± 0.58
Single encapsulated Quercetin PLGA 75:25 - 25.44 ± 1.17
Single encapsulated Quercetin PLA - 33.6 ± 1.68
Co-encapsulated β-carotene and Quercetin PLGA 50:50 1.49 ± 0.08 24.11 ± 1.21
Co-encapsulated β-carotene and Quercetin PLGA 75:25 3.56 ± 0.18 28.25 ± 1.41
Co-encapsulated β-carotene and Quercetin PLA 7.28 ± 0.36 49.30 ± 3.55
PURPOSE
INTRODUCTION
• β-Carotene (Bc) and Quercetin (Qu) are two naturally occurring antioxidants with a log P of 15 and 2,
respectively.
• Poly(L-)Lactic acid (PLA) and Polylacticglycolic acid (PLGA) are biodegradable polymers that are known
to be used for extended/sustained release of drugs.
• Encapsulation of molecules within nanoparticles had previously been demonstrated to increase the
efficiency of drug targeting
• A co-encapsulated nanoparticle containing β-Carotene and Quercetin may demonstrate a synergistic
antioxidant effect
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•β-Carotene and quercetin were prepared (single and co-encapsulation) using a biodegradable
polymer by emulsification/solvent evaporation technique
•A number of formulation approaches varying in drug/polymer concentration were investigated
•A known amount of the antioxidants (5 mg each) were encapsulated using either PLA, PLGA (75:25)
or PLGA (50:50). PVA (115K) was used as the surfactant
•The nanoparticles were characterised for particle size and zeta-potential using the Zetasizer
•Loading efficiency of the nanoparticles was determined by selectively extracting quercetin into a
mixture of acidified methanol (60%) and water (40%) followed by extracting β-Carotene into DCM.
The samples were analysed by RP-HPLC
•FT-IR spectra were obtained to determine the presence of any non-encapsulated drug particles in the
samples and Scanning electron microscopy (JEOL-JSM6310) was performed to examine the
morphology and particle size distribution.
•Antioxidant activity was determined using the modified ABTS, (2,2 -azino bis (3-ethylbenzthiazoline-6-
sulphonic acid)) radical cation scavenging assay where percentage reduction of absorbance of the
radical cation was measured by spectrophotometry
•Antioxidant activity of blank, single and co-encapsulated nanoparticles was measured over a 24 hour
period. Activity was compared using standard antioxidant solutions.
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Figure 1: SEM images of nanoparticles (coated with palladium). A: PLA co-encapsulated, B: PLGA 75:25 co-
encapsulated, C: PLGA50:50, D: PLA co-encapsulated, E: PLGA75:25 co-encapsulated, F: PLGA co-encapsulated
Figure 2: FT-IR spectra of PLA co-
encapsulated sample. Only the bond 
intensities for the polymer were detected
Figure 3: Size distribution of PLA co-
encapsulated nanoparticle sample. Mean 
particle size was measured to be 270 ± 12 nm
Figure 5: Representative chromatogram 
of HPLC analysis of β-carotene 
(methanol:DCM:MeCN 20:25:55)
Figure 4: Representative chromatogram of HPLC 
analysis of Quercetin (A [methanol: water:0.1N 
HCl 60:39.5:0.5] 60%: B [MeCN] 40%)
Table 1: Loading efficiency of the nanoparticles with the two antioxidants (n=3)
RESULTS
Table 2: Mean particle size and zeta potential of single-encapsulated and co-encapsulated nanoparticles  
(using either PLA, PLGA75:25 or PLGA 50:50) containing β-carotene and Quercetin
Figure 6: Comparison of antioxidant activity of co-encapsulated nanoparticles with single encapsulated 
nanoparticles for Quercetin (A) and β-Carotene (B)
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• Quercetin and β-carotene were successfully co-encapsulated in nanoparticles
• Quercetin was encapsulated to a greater extent than β-carotene 
• However, significantly higher amount of β-carotene was encapsulated when co-encapsulated with 
quercetin than when single encapsulated. This observation was found to be true with all the polymers 
tested.
• Mean particle size for all the nanoparticles ranged between 240 to 300 nm
• The negative zeta potential observed indicates a stable suspension of the nanoparticles when dispersed in 
a solution
• Antioxidant activity of the compounds when encapsulated was observed to have a faster rate of reaction 
when co-encapsulated. Nanoparticles containing quercetin alone had a faster rate of reaction compared 
to β-carotene  encapsulated nanoparticles. 
• The observations made in this study can increase the potential to develop nanotechnology as a means of 
delivering a combination of antioxidants/drugs for various health benefits
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